OKI-179, an Oral Class 1-selective Depsipeptide HDAC Inhibitor: Phase 1 Results & Phase 2 Plans

Time: 1:00 pm
day: Day One

Details:

  • OKI-179 is an oral depsipeptide HDAC Class 1 inhibitor, the same class as the IV drug romidepsin
  • Demonstrating how OKI-179 has completed Phase 1 with excellent PK, PD and safety
  • Discussing a molecular approach to Phase 2 trials

Speakers: